Todd Giorgio

by Bill Snyder The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs can be “repolarized,” converted from immunosuppressive tumor-promoters to inflammatory tumor-fighters. Now, Associate Professor of Pharmacology Fiona Yull,... Read More

Three engineering faculty members have received grants to support the early stages of pioneering research projects identified as likely candidates for further funding from federal, foundation and industry sponsors. Spring 2022 Seeding Success Grants were awarded to 14 faculty and are the second cycle of the internal early investment funding initiative. The grants, awarded to faculty spanning the... Read More

Alumni Charleson and Charreau Bell are siblings, business partners, innovators and entrepreneurs, as well as emblematic of the culture of innovation at Vanderbilt's Wond’ry and Data Science Institute. Read More

For the second year in a row, Vanderbilt students came to Washington, D.C., to participate in a two-day workshop designed to introduce them to federal issues and advocacy related to science, technology, engineering and math. Read More

Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells. Read More

Vanderbilt students explored the opportunities and challenges of setting policy on federal issues and advocacy related to science, technology, engineering and math during a two-day immersion event last week in Washington, D.C. Read More

One of the first such programs in the United States, Vanderbilt’s Department of Biomedical Engineering is celebrating its 45th anniversary as a program and its 25th anniversary as a department in the School of Engineering. Read More

Vanderbilt graduate student Charleson Bell, who is the president of the high tech startup BioNanovations, is participating in a 12-week accelerator program in Silicon Valley specifically designed to encourage underrepresented tech entrepeneurs. Read More